highly significantp < 0.05
The treatment with linagliptin, diosmin, and a combination of them produced a highly significant alleviation ( p < 0.05) of the liver glycogen content, recording 43.30 ± 1.47, 43.4 ± 1.11, and 27.90 ± 1.48 mg/g tissue, respectively ( Figure 4 A).